Nayanika Chakraborty

Dr. Nayanika Chakraborty

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
NCNayanika Chakraborty
Nayanika Chakraborty
SGSona Gandhi
Sona Gandhi
Rajni VermaRajni Verma
Rajni Verma
IRIndrajit ROY
Indrajit ROY
The ability of some nanoparticles to mimic the activity of certain enzymes paves the way for several attractive biomedical applications which bolster the already impressive arsenal of nanomaterials to combat deadly diseases. A key feature of such ‘nanozymes’ is the duplication of activities of enzymes or classes of enzymes, such as catalase, superoxide dismutase, oxidase, and peroxidase which are known to modulate the oxidative balance of treated cells for facilitating a particular biological process such as cellular apoptosis. Several nanoparticles that include those of metals, metal oxides/sulfides, metal–organic frameworks, carbon-based materials, etc., have shown the ability to behave as one or more of such enzymes. As compared to natural enzymes, these artificial nanozymes are safer, less expensive, and more stable. Moreover, their catalytic activity can be tuned by changing their size, shape, surface properties, etc. In addition, they can also be engineered to demonstrate additional features, such as photoactivated hyperthermia, or be loaded with active agents for multimodal action. Several researchers have explored the nanozyme-mediated oxidative modulation for therapeutic purposes, often in combination with other diagnostic and/or therapeutic modalities, using a single probe. It has been observed that such synergistic action can effectively by-pass the various defense mechanisms adapted by rogue cells such as hypoxia, evasion of immuno-recognition, drug-rejection, etc. The emerging prospects of using several such nanoparticle platforms for the treatment of bacterial infections/diseases and cancer, along with various related challenges and opportunities, are discussed in this review.

20 December 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NCNayanika Chakraborty
Nayanika Chakraborty
IRIndrajit Roy
Indrajit Roy
PKPradeep Kumar
Pradeep Kumar
SSSwati Singh
Swati Singh
Rajiv PathakRajiv Pathak
Rajiv Pathak
HGHemant Kumar Gautam
Hemant Kumar Gautam
Prussian blue nanoparticles (PBNPs) have gained significant attraction in the field of nanomedicine due to their excellent biocompatibility, potential for nanoscale production, exceptional photothermal conversion ability, and multi-enzyme mimicking capabilities. PBNPs have made considerable advancements in their application to biomedical fields. This review embarks with a comprehensive understanding of the physicochemical properties and chemical profiling of PB-based nanoparticles, discussing systematic approaches to tune their dimensions, shapes, and sizes, as well as their biomedical properties. Subsequently, the use of PB-based NPs in the biomedical sector is extensively discussed and categorized based on the various features of modified PBNPs, either in combination with drugs or their analogues. Finally, the article highlights the existing challenges associated with current studies and explores the latest developments in these rapidly evolving PB-based nanoplatforms and their therapeutic potentials. Overall, this review aims to deepen the understanding of PB-based NPs and provide crucial insights into their rational design in disease treatment.

30 October 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
NCNayanika Chakraborty
Nayanika Chakraborty
DJDiksha Jha
Diksha Jha
Vijay Pal SinghVijay Pal Singh
Vijay Pal Singh
PKPradeep Kumar
Pradeep Kumar
NVNavin Kumar Verma
Navin Kumar Verma
IRIndrajit ROY
Indrajit ROY